Observing the epidemiology of visceral leishmaniasis in Emilia-Romagna

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze the epidemiology of visceral leishmaniasis (LV) in the Province of Bologna, where there has been a noted increase in cases since 2012. By conducting a retrospective prospective analysis, the study seeks to establish a scientific basis for developing guidelines that standardize diagnostic and therapeutic approaches to LV. The goal is to reduce diagnostic delays and improve treatment outcomes, while also identifying new strategies for disease control to minimize transmission. The study will include patients of all ages with a confirmed diagnosis of LV who provide informed consent.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of any age with microbiologically established diagnosis of LV.
* Obtaining Informed Consent.

Exclusion Criteria:

* not having obtained Informed Consent

Where it's running

• Ospedale M. Bufalini di Cesena, AUSL della Romagna
  Cesena, Forlì-Cesena, Italy Recruiting
• Ospedale G.B. Morgagni L. Pierantoni di Forlì
  Forlì, Forlì-Cesena, Italy Recruiting
• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting
• Ospedale S. Maria delle Croci di Ravenna, AUSL della Romagna
  Ravenna, Italy Recruiting
• Ospedale Infermi di Rimini, AUSL della Romagna
  Rimini, Italy Recruiting

Study contacts

• Principal investigator: Pierluigi Viale, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Pierluigi Viale, MD
• Email: pierluigi.viale@unibo.it
• Phone: +390512143353

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Immunogenicity screening of Leishmania vaccine candidate antigens in Ethiopian patients

  This study tests whether six Leishmania vaccine candidate antigens can trigger T-cell responses in patients with cutaneous or visceral leishmaniasis.

  Recruiting at 2 sites Institute of Tropical Medicine, Belgium · Addis Ababa and 1 other locations · NCT07783243

• Pediatric leishmaniasis in Italy: clinical and treatment patterns

  This project will collect medical information to see how leishmaniasis presents and is treated in children under 18 in Italy.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Tuscany · NCT07504757

• Risk factors for outcomes after surgery for very large intrathoracic tumors

  This study tests how patients with very large chest tumors fare after surgical removal, to see which factors are linked to better or worse outcomes.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07926490

• IBS and rosacea in adults: how common is rosacea among people with IBS at a university center

  This observational study tests how often rosacea occurs in adults with IBS who are treated at a university hospital in Bologna.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Italy · NCT07922668

• INSL3 as a Biomarker to See If Puberty Has Started

  Researchers are testing whether a single blood test for INSL3 can tell if a child’s puberty has begun, potentially reducing need for the GnRH stimulation test.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT07859787

• Ultrasound-guided pelvic floor training to help birth in first-time pregnant women

  This study tests if real-time ultrasound feedback on pelvic floor muscles during labor preparation helps shorten the second stage of labor in first-time pregnant women with specific pelvic floor muscle activation.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07675642

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.